Intranasal Drug Delivery Devices Market By System (Metered Dose, Multi-Dose Systems, Unit-Dose Systems) , By Container (Non-Pressurized Containers, Pressurized Containers) By Application (Chronic Obstructive Pulmonary Disease, Rhinitis, Cystic Fibrosis,
Description
Intranasal Drug Delivery Devices Market By System (Metered Dose, Multi-Dose Systems, Unit-Dose Systems) , By Container (Non-Pressurized Containers, Pressurized Containers) By Application (Chronic Obstructive Pulmonary Disease, Rhinitis, Cystic Fibrosis, Nasal Congestion, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The intranasal drug delivery devices market was valued at $1.7 billion in 2023, and is projected to reach $3.8 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.
Intranasal drug delivery devices are medical devices designed to administer therapeutic agents through the nasal cavity. This route of administration provides a non-invasive and efficient means to deliver drugs directly into the systemic circulation or target the central nervous system, bypassing the gastrointestinal tract and first-pass metabolism in the liver. Intranasal devices commonly include nasal sprays, nebulizers, and powder dispensers, tailored to enhance drug absorption through the nasal mucosa.
The growth of the global intranasal drug delivery devices market is driven by alarming increase in prevalence of respiratory diseases, allergies, migraines as well as conditions requiring rapid drug action, such as epilepsy and opioid overdose. According to a study published by the Institute for Health Metrics and Evaluation—a public health research institute—chronic respiratory diseases were responsible for 4.0 million deaths with a prevalence of 454.6 million cases in 2019, ranking as the third leading cause of death. In addition, surge in demand for non-invasive drug delivery methods among patients is boosting the adoption of intranasal devices for both chronic and acute conditions. Moreover, intranasal drug delivery is effective in targeting the central nervous system, as it allows drugs to bypass the blood-brain barrier. This is fostering research into treatments for neurological disorders, such as Alzheimer’s and Parkinson’s disease. Furthermore, rise of home healthcare and self-medication trends is driving the demand for easy-to-use drug delivery systems, including intranasal devices, which significantly fosters the market growth. However, frequent use of intranasal devices may cause irritation, dryness, or other discomfort in the nasal mucosa, which limits their adoption, thereby hampering the market growth. In addition, not all drugs are suitable for intranasal delivery due to stability issues or low permeability through the nasal mucosa, which restricts the range of applications for these devices. On the contrary, innovations such as metered-dose nasal sprays and needle-free devices improve drug delivery precision and user-friendliness. Smart devices integrated with sensors for dose tracking are also emerging, enhancing patient adherence. Such developments are expected to offer remunerative opportunities for the expansion of the global market during the forecast.
The intranasal drug delivery devices industry is segmented into system, container, application, and region. By system, the market is segregated into metered dose, multi-dose systems, and unit-dose systems. On the basis of containers, it is bifurcated into non-pressurized containers and pressurized containers. Depending on application, it is divided into chronic obstructive pulmonary disease (COPD) , rhinitis, cystic fibrosis, nasal congestion, asthma, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By system, the multi-dose systems segment is expected to dominate the market from 2024 to 2033.
On the basis of container, the non-pressurized system containers segment is anticipated to exhibit the highest growth during the forecast period.
Depending on application, the asthma segment is projected to grow at a notable pace in the near future.
Region wise, North America held the largest market share in the intranasal drug delivery devices market in 2023, and is expected to dominate the market during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global intranasal drug delivery devices market include AptarGroup, Inc., Teleflex Incorporated, Nemera, Becton, Dickinson and Company, OptiNose, Inc., GlaxoSmithKline Plc., AstraZeneca, Kurve Technology, Inc., Johnson & Johnson, and Merck & Co., Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.
Key Market Segments
By System
Metered Dose
Multi-Dose Systems
Unit-Dose Systems
By Container
Non-Pressurized Containers
Pressurized Containers
By Application
Chronic Obstructive Pulmonary Disease
Rhinitis
Cystic Fibrosis
Nasal Congestion
Others
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
AptarGroup, Inc.
Teleflex Incorporated
nemera
Becton, Dickinson and Company
OptiNose, Inc.
GlaxoSmithKline plc.
AstraZeneca
Kurve Technology, Inc.
Johnson & Johnson
Merck & Co., Inc.
Table of Contents
260 Pages
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By System
- 4.2. Metered Dose
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Multi-Dose Systems
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Unit-Dose Systems
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- CHAPTER 5: INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Container
- 5.2. Non-Pressurized Containers
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Pressurized Containers
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- CHAPTER 6: INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Application
- 6.2. Chronic Obstructive Pulmonary Disease
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Rhinitis
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Cystic Fibrosis
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5. Nasal Congestion
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
- 6.6. Others
- 6.6.1. Key Market Trends, Growth Factors and Opportunities
- 6.6.2. Market Size and Forecast, By Region
- 6.6.3. Market Share Analysis, By Country
- CHAPTER 7: INTRANASAL DRUG DELIVERY DEVICES MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By System
- 7.2.3. Market Size and Forecast, By Container
- 7.2.4. Market Size and Forecast, By Application
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Intranasal Drug Delivery Devices Market
- 7.2.6.1. Market Size and Forecast, By System
- 7.2.6.2. Market Size and Forecast, By Container
- 7.2.6.3. Market Size and Forecast, By Application
- 7.2.7. Canada Intranasal Drug Delivery Devices Market
- 7.2.7.1. Market Size and Forecast, By System
- 7.2.7.2. Market Size and Forecast, By Container
- 7.2.7.3. Market Size and Forecast, By Application
- 7.2.8. Mexico Intranasal Drug Delivery Devices Market
- 7.2.8.1. Market Size and Forecast, By System
- 7.2.8.2. Market Size and Forecast, By Container
- 7.2.8.3. Market Size and Forecast, By Application
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By System
- 7.3.3. Market Size and Forecast, By Container
- 7.3.4. Market Size and Forecast, By Application
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Intranasal Drug Delivery Devices Market
- 7.3.6.1. Market Size and Forecast, By System
- 7.3.6.2. Market Size and Forecast, By Container
- 7.3.6.3. Market Size and Forecast, By Application
- 7.3.7. Germany Intranasal Drug Delivery Devices Market
- 7.3.7.1. Market Size and Forecast, By System
- 7.3.7.2. Market Size and Forecast, By Container
- 7.3.7.3. Market Size and Forecast, By Application
- 7.3.8. Italy Intranasal Drug Delivery Devices Market
- 7.3.8.1. Market Size and Forecast, By System
- 7.3.8.2. Market Size and Forecast, By Container
- 7.3.8.3. Market Size and Forecast, By Application
- 7.3.9. Spain Intranasal Drug Delivery Devices Market
- 7.3.9.1. Market Size and Forecast, By System
- 7.3.9.2. Market Size and Forecast, By Container
- 7.3.9.3. Market Size and Forecast, By Application
- 7.3.10. UK Intranasal Drug Delivery Devices Market
- 7.3.10.1. Market Size and Forecast, By System
- 7.3.10.2. Market Size and Forecast, By Container
- 7.3.10.3. Market Size and Forecast, By Application
- 7.3.11. Rest Of Europe Intranasal Drug Delivery Devices Market
- 7.3.11.1. Market Size and Forecast, By System
- 7.3.11.2. Market Size and Forecast, By Container
- 7.3.11.3. Market Size and Forecast, By Application
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By System
- 7.4.3. Market Size and Forecast, By Container
- 7.4.4. Market Size and Forecast, By Application
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Intranasal Drug Delivery Devices Market
- 7.4.6.1. Market Size and Forecast, By System
- 7.4.6.2. Market Size and Forecast, By Container
- 7.4.6.3. Market Size and Forecast, By Application
- 7.4.7. Japan Intranasal Drug Delivery Devices Market
- 7.4.7.1. Market Size and Forecast, By System
- 7.4.7.2. Market Size and Forecast, By Container
- 7.4.7.3. Market Size and Forecast, By Application
- 7.4.8. India Intranasal Drug Delivery Devices Market
- 7.4.8.1. Market Size and Forecast, By System
- 7.4.8.2. Market Size and Forecast, By Container
- 7.4.8.3. Market Size and Forecast, By Application
- 7.4.9. South Korea Intranasal Drug Delivery Devices Market
- 7.4.9.1. Market Size and Forecast, By System
- 7.4.9.2. Market Size and Forecast, By Container
- 7.4.9.3. Market Size and Forecast, By Application
- 7.4.10. Australia Intranasal Drug Delivery Devices Market
- 7.4.10.1. Market Size and Forecast, By System
- 7.4.10.2. Market Size and Forecast, By Container
- 7.4.10.3. Market Size and Forecast, By Application
- 7.4.11. Rest of Asia-Pacific Intranasal Drug Delivery Devices Market
- 7.4.11.1. Market Size and Forecast, By System
- 7.4.11.2. Market Size and Forecast, By Container
- 7.4.11.3. Market Size and Forecast, By Application
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By System
- 7.5.3. Market Size and Forecast, By Container
- 7.5.4. Market Size and Forecast, By Application
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Intranasal Drug Delivery Devices Market
- 7.5.6.1. Market Size and Forecast, By System
- 7.5.6.2. Market Size and Forecast, By Container
- 7.5.6.3. Market Size and Forecast, By Application
- 7.5.7. South Africa Intranasal Drug Delivery Devices Market
- 7.5.7.1. Market Size and Forecast, By System
- 7.5.7.2. Market Size and Forecast, By Container
- 7.5.7.3. Market Size and Forecast, By Application
- 7.5.8. Saudi Arabia Intranasal Drug Delivery Devices Market
- 7.5.8.1. Market Size and Forecast, By System
- 7.5.8.2. Market Size and Forecast, By Container
- 7.5.8.3. Market Size and Forecast, By Application
- 7.5.9. Rest of LAMEA Intranasal Drug Delivery Devices Market
- 7.5.9.1. Market Size and Forecast, By System
- 7.5.9.2. Market Size and Forecast, By Container
- 7.5.9.3. Market Size and Forecast, By Application
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. AptarGroup, Inc.
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Teleflex Incorporated
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Nemera
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Becton, Dickinson And Company
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. OptiNose, Inc.
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. GlaxoSmithKline Plc.
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. AstraZeneca
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Kurve Technology, Inc.
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Johnson And Johnson
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Merck And Co., Inc.
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 2. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR METERED DOSE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR MULTI-DOSE SYSTEMS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR UNIT-DOSE SYSTEMS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. GLOBAL INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 6. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR NON-PRESSURIZED CONTAINERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR PRESSURIZED CONTAINERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. GLOBAL INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 9. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR RHINITIS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR CYSTIC FIBROSIS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR NASAL CONGESTION, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. INTRANASAL DRUG DELIVERY DEVICES MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. NORTH AMERICA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 16. NORTH AMERICA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 17. NORTH AMERICA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 18. NORTH AMERICA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 19. U.S. INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 20. U.S. INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 21. U.S. INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 22. CANADA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 23. CANADA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 24. CANADA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 25. MEXICO INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 26. MEXICO INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 27. MEXICO INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 28. EUROPE INTRANASAL DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 29. EUROPE INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 30. EUROPE INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 31. EUROPE INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 32. FRANCE INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 33. FRANCE INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 34. FRANCE INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 35. GERMANY INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 36. GERMANY INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 37. GERMANY INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 38. ITALY INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 39. ITALY INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 40. ITALY INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 41. SPAIN INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 42. SPAIN INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 43. SPAIN INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 44. UK INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 45. UK INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 46. UK INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 47. REST OF EUROPE INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 48. REST OF EUROPE INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 49. REST OF EUROPE INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 50. ASIA-PACIFIC INTRANASAL DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 51. ASIA-PACIFIC INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 52. ASIA-PACIFIC INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 53. ASIA-PACIFIC INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 54. CHINA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 55. CHINA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 56. CHINA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 57. JAPAN INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 58. JAPAN INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 59. JAPAN INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 60. INDIA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 61. INDIA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 62. INDIA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 63. SOUTH KOREA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 64. SOUTH KOREA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 65. SOUTH KOREA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 66. AUSTRALIA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 67. AUSTRALIA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 68. AUSTRALIA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 69. REST OF ASIA-PACIFIC INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 70. REST OF ASIA-PACIFIC INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 71. REST OF ASIA-PACIFIC INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 72. LAMEA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 73. LAMEA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 74. LAMEA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 75. LAMEA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 76. BRAZIL INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 77. BRAZIL INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 78. BRAZIL INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 79. SOUTH AFRICA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 80. SOUTH AFRICA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 81. SOUTH AFRICA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 82. SAUDI ARABIA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 83. SAUDI ARABIA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 84. SAUDI ARABIA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 85. REST OF LAMEA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY SYSTEM, 2024 - 2033 ($BILLION)
- TABLE 86. REST OF LAMEA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY CONTAINER, 2024 - 2033 ($BILLION)
- TABLE 87. REST OF LAMEA INTRANASAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 88. APTARGROUP, INC.: KEY EXECUTIVES
- TABLE 89. APTARGROUP, INC.: COMPANY SNAPSHOT
- TABLE 90. APTARGROUP, INC.: OPERATING SEGMENTS
- TABLE 91. APTARGROUP, INC.: PRODUCT PORTFOLIO
- TABLE 92. APTARGROUP, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 93. TELEFLEX INCORPORATED: KEY EXECUTIVES
- TABLE 94. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
- TABLE 95. TELEFLEX INCORPORATED: OPERATING SEGMENTS
- TABLE 96. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
- TABLE 97. TELEFLEX INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 98. NEMERA: KEY EXECUTIVES
- TABLE 99. NEMERA: COMPANY SNAPSHOT
- TABLE 100. NEMERA: OPERATING SEGMENTS
- TABLE 101. NEMERA: PRODUCT PORTFOLIO
- TABLE 102. NEMERA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 103. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
- TABLE 104. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 105. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 106. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 107. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 108. OPTINOSE, INC.: KEY EXECUTIVES
- TABLE 109. OPTINOSE, INC.: COMPANY SNAPSHOT
- TABLE 110. OPTINOSE, INC.: OPERATING SEGMENTS
- TABLE 111. OPTINOSE, INC.: PRODUCT PORTFOLIO
- TABLE 112. OPTINOSE, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 113. GLAXOSMITHKLINE PLC.: KEY EXECUTIVES
- TABLE 114. GLAXOSMITHKLINE PLC.: COMPANY SNAPSHOT
- TABLE 115. GLAXOSMITHKLINE PLC.: OPERATING SEGMENTS
- TABLE 116. GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
- TABLE 117. GLAXOSMITHKLINE PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 118. ASTRAZENECA: KEY EXECUTIVES
- TABLE 119. ASTRAZENECA: COMPANY SNAPSHOT
- TABLE 120. ASTRAZENECA: OPERATING SEGMENTS
- TABLE 121. ASTRAZENECA: PRODUCT PORTFOLIO
- TABLE 122. ASTRAZENECA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 123. KURVE TECHNOLOGY, INC.: KEY EXECUTIVES
- TABLE 124. KURVE TECHNOLOGY, INC.: COMPANY SNAPSHOT
- TABLE 125. KURVE TECHNOLOGY, INC.: OPERATING SEGMENTS
- TABLE 126. KURVE TECHNOLOGY, INC.: PRODUCT PORTFOLIO
- TABLE 127. KURVE TECHNOLOGY, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 128. JOHNSON AND JOHNSON: KEY EXECUTIVES
- TABLE 129. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
- TABLE 130. JOHNSON AND JOHNSON: OPERATING SEGMENTS
- TABLE 131. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
- TABLE 132. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 133. MERCK AND CO., INC.: KEY EXECUTIVES
- TABLE 134. MERCK AND CO., INC.: COMPANY SNAPSHOT
- TABLE 135. MERCK AND CO., INC.: OPERATING SEGMENTS
- TABLE 136. MERCK AND CO., INC.: PRODUCT PORTFOLIO
- TABLE 137. MERCK AND CO., INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL INTRANASAL DRUG DELIVERY DEVICES MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF INTRANASAL DRUG DELIVERY DEVICES MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN INTRANASAL DRUG DELIVERY DEVICES MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALINTRANASAL DRUG DELIVERY DEVICES MARKET
- FIGURE 10. GLOBAL INTRANASAL DRUG DELIVERY DEVICES MARKET SEGMENTATION, BY SYSTEM
- FIGURE 11. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR METERED DOSE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR MULTI-DOSE SYSTEMS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR UNIT-DOSE SYSTEMS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. GLOBAL INTRANASAL DRUG DELIVERY DEVICES MARKET SEGMENTATION, BY CONTAINER
- FIGURE 15. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR NON-PRESSURIZED CONTAINERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR PRESSURIZED CONTAINERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. GLOBAL INTRANASAL DRUG DELIVERY DEVICES MARKET SEGMENTATION, BY APPLICATION
- FIGURE 18. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR RHINITIS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR CYSTIC FIBROSIS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR NASAL CONGESTION, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. INTRANASAL DRUG DELIVERY DEVICES MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 27. COMPETITIVE DASHBOARD
- FIGURE 28. COMPETITIVE HEATMAP: INTRANASAL DRUG DELIVERY DEVICES MARKET
- FIGURE 29. TOP PLAYER POSITIONING, 2023
- FIGURE 30. APTARGROUP, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 31. APTARGROUP, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 32. APTARGROUP, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 33. TELEFLEX INCORPORATED: NET SALES, 2021-2023 ($BILLION)
- FIGURE 34. TELEFLEX INCORPORATED: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. TELEFLEX INCORPORATED: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. NEMERA: NET SALES, 2021-2023 ($BILLION)
- FIGURE 37. NEMERA: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. NEMERA: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. BECTON, DICKINSON AND COMPANY: NET SALES, 2021-2023 ($BILLION)
- FIGURE 40. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. OPTINOSE, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 43. OPTINOSE, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. OPTINOSE, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. GLAXOSMITHKLINE PLC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 46. GLAXOSMITHKLINE PLC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. GLAXOSMITHKLINE PLC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. ASTRAZENECA: NET SALES, 2021-2023 ($BILLION)
- FIGURE 49. ASTRAZENECA: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. ASTRAZENECA: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 51. KURVE TECHNOLOGY, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 52. KURVE TECHNOLOGY, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 53. KURVE TECHNOLOGY, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 54. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($BILLION)
- FIGURE 55. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 56. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 57. MERCK AND CO., INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 58. MERCK AND CO., INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 59. MERCK AND CO., INC.: REVENUE SHARE, BY REGION, 2023 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
